Survey of Ophthalmology
Volume 42, Issue 4 , Pages 360-366 , January 1998

Ocular Side Effects of Amiodarone

References 

  1. Alzner E. Hornhauteinlagerungen infolge Amiodaron-Therapie. Klin Monatsbl Augenheilkd. 1984;185:333–334
  2. Bockhardt H, Drenckhahn D, Lüllmann-Rauch R. Amiodarone-induced lipidosis-like alterations in ocular tissues of rats. Graefes Arch Clin Exp Ophthalmol. 1978;207:91–96
  3. D’Amico DJ, Kenyon KR, Ruskin JN. Amiodarone keratopathy. Drug-induced lipid storage disease. Arch Ophthalmol. 1981;99:257–261
  4. Dickinson EJ, Wolman RL. Sicca syndrome associated with amiodarone therapy. BMJ. 1986;293:510
  5. Dolan BJ, Flach AJ, Peterson JS. Amiodarone keratopathy and lens opacities. J Am Optom Assoc. 1985;54:468–470
  6. Duff GR, Fraser AG. Impairment of colour vision associated with amiodarone keratopathy. Acta Ophthalmol. 1987;65:48–52
  7. Dunn M, Glassroth J. Pulmonary complications of amiodarone toxicity. Prog Cardiovasc Dis. 1989;31:447–453
  8. Feiner LA, Younge BR, Kazmier JF, et al.  Optic neuropathy and amiodarone therapy. Mayo Clin Proc. 1987;62:702–717
  9. Flach AJ, Dolan BJ. Progression of amiodarone induced cataracts. Doc Ophthalmol. 1993;83:323–329
  10. Flach AJ, Dolan BJ, Sudduth B, Weddell J. Amiodarone-induced lens opacities. Arch Ophthalmol. 1983;101:1554–1556
  11. Flach AJ, Peterson JS, Dolan BJ. Anterior subcapsular cataracts (a review of potential etiologies). Ann Ophthalmol. 1985;17:78–80
  12. François J. Cornea verticillata. Doc Ophthalmol. 1969;27:235–250
  13. Garrett SN, Kearney JJ, Schiffman JS. Amiodarone optic neuropathy. J Clin Neuroophthalmol. 1988;8:105–110
  14. Garrett SN, Waterhouse WJ, Parmley VC. Amiodarone keratopathy in the donor cornea. Am J Ophthalmol. 1988;105:425–427
  15. Ghosh M, McCulloch C. Amiodarone-induced ultrastructural changes in human eyes. Can J Ophthalmol. 1984;19:178–186
  16. Gittinger JW, Asdourian GK. Papillopathy caused by amiodarone. Arch Ophthalmol. 1987;105:349–351
  17. Greene HL, Graham EL, Werner JA, et al.  Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias. J Am Coll Cardiol. 1983;2:1114–1128
  18. Harris L, McKenna WJ, Rowland E, Krikler DM. Side effects and possible contraindications of amiodarone use. Am Heart J. 1983;106:916–922
  19. Haug SJ, Friedman AH. Identification of amiodarone in corneal deposits. Am J Ophthalmol. 1991;111:518–519
  20. Hirst LW, Sanborn G, Green WR, et al.  Amodiaquine ocular changes. Arch Ophthalmol. 1982;100:1300–1304
  21. Hyatt RH, Sinha B, Vallon A, et al.  Noncardiac side-effects of long-term oral amiodarone in the elderly. Age Ageing. 1988;17:116–122
  22. Ingram DV. Ocular effects in long-term amiodarone therapy. Am Heart J. 1983;106:902–905
  23. Ingram DV, Jaggarao NSV, Chamberlain DA. Ocular changes resulting from therapy with amiodarone. Br J Ophthalmol. 1982;66:676–679
  24. Kaplan LJ, Cappaert WE. Amiodarone keratopathy. Correlation to dosage and duration. Arch Ophthalmol. 1982;100:601–602
  25. Kerin NZ, Aragon E, Faitel K, et al.  Long-term efficacy and toxicity of high- and low-dose amiodarone regimens. J Clin Pharmacol. 1989;29:418–423
  26. Krieg P, Schipper I. Bilaterale Optikusneuropathie nach Amiodarone-Therapie. Klin Monatsbl Augenheilkd. 1992;200:128–132
  27. Mansour AM, Puklin JE, O’Grady R. Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol. 1988;8:231–237
  28. McNeil JJ, Sloman JG: Cardiovascular diseases, in Speight TM (ed): Avery’s Drug Treatment. Edinburgh, Auckland, Churchill Livingstone, Adis Press, 1987, ed 3, pp 633–635
  29. Nazarian SM, Jay WM. Bilateral optic neuropathy associated with amiodarone therapy. J Clin Neuroophthalmol. 1988;8:25–28
  30. Nielsen CE, Andreasen F, Bjerregaard P. Amiodarone induced cornea verticillata. Acta Ophthalmol. 1983;61:474–480
  31. Orlando RG, Dangel ME, Schaal SF. Clinical experience and grading of amiodarone keratopathy. Ophthalmology. 1984;91:1184–1187
  32. Palmeri S, Battisti C, Malandrini A, Federico A. Amiodarone induced lipidosis similar to Niemann-Pick C disease. Biochemical and morphological study. Life Sci. 1995;57:1963–1971
  33. Raeder EA, Podrid PJ, Lown B. Side effects and complications of amiodarone therapy. Am Heart J. 1985;109:975–983
  34. Reifler DM, Verdier DD, Davy CL, et al.  Multiple chalazia and rosacea in a patient treated with amiodarone. Am J Ophthalmol. 1987;103:594–595
  35. Riegel EM, Pokorny KS, Friedman AH, et al.  Ocular pathology of Fabry’s disease in a hemizygous male following renal transplantation. Surv Ophthalmol. 1982;26:247–252
  36. Roden DM: Antiarrhythmic drugs, in Hardman JG, Limbird LE, Molinoff PB, et al (eds): Goodman and Gilman’s The Pharmacological Basis of Therapeutics. New York, McGraw-Hill, 1996, ed 9, pp 858–862
  37. Sedwick LA. Getting to the heart of visual loss (when cardiac medication may be dangerous to the optic nerves). Surv Ophthalmol. 1992;36:366–372
  38. Seiler KU, Thiel HJ, Wasserman O. Die Chloroquinkeratopathie als Beispiel einer arzneimittelinduzierten Phospholipidosis. Klin Monatsbl Aguenheilkd. 1977;170:64–73
  39. Thystrup JD, Fledelius HC. Retinal maculopathy possibly associated with amiodarone medication. Acta Ophthalmol. 1994;72:639–641
  40. Tuppurainen K, Collan Y, Rantanen T, Hollmen A. Fabry’s disease and cornea verticillata. Acta Ophthalmol. 1981;59:674–682
  41. Verriest G, Van Laethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores. Am J Ophthalmol. 1982;93:635–642
  42. Vrobel TR, Miller PE, Mostow ND, Rakita L. A general overview of amiodarone toxicity (its prevention, detection, and management). Prog Cardiovasc Dis. 1989;31:393–426
  43. Weingeist TA, Blodi FC. Fabry’s disease (ocular findings in a female carrier). Arch Ophthalmol. 1971;85:169–176
  44. Younge BR, Smith JL. Amiodarone optic neuropathy (Editorial). J Clin Neuroophthalmol. 1988;8:29
  45. Zachary CB, Slater DN, Holt DW, et al.  The pathogenesis of amiodarone-induced pigmentation and photosensitivity. Br J Dermatol. 1984;110:451–456

PII: S0039-6257(97)00118-5

doi: 10.1016/S0039-6257(97)00118-5

Survey of Ophthalmology
Volume 42, Issue 4 , Pages 360-366 , January 1998

Article Tools

* Image Usage & Resolution